Airsculpt Technologies, Inc.(AIRS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,468 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
AIRS Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Airsculpt Technologies, Inc. (AIRS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AIRS at 31.1/100 on a 32-signal composite quality model, placing it at rank #2,468 of 2,962 stocks — the bottom half of the AI-ranked universe. AIRS scores in the top quartile across institutional flow (79.6). Areas of concern include revenue growth (6.7) and revenue scale (20.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Airsculpt Technologies, Inc. reports quarterly revenue of $39.4M, net income of $-2.4M, an operating margin of -4.6%. Top institutional holders of AIRS by reported 13-F value include Vesey Street Capital Partners, L.L.C., THRIVENT FINANCIAL FOR LUTHERANS, BlackRock, based on the most recent SEC filings. AIRS trades on the Nasdaq exchange and files with the SEC under CIK 1870940. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AIRS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Airsculpt Technologies, Inc. directly from SEC EDGAR. Airsculpt Technologies, Inc.'s 13F Pro composite quality score has ranged between 25 and 56 since 2022, currently 31.1 — a declining long-term trajectory across 62 quarterly and live scoring snapshots.
Revenue
Q1 2026
$39.4M
Net Income
Q1 2026
$-2.4M
Free Cash Flow
Q1 2026
$5.2M
Operating Margin
Q1 2026
-4.6%
ROIC
Q1 2026
-4.8%
D/E Ratio
Q1 2026
0.50
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-15.8% YoYNet Income
-45.5% YoYOperating Income
-630.3% YoYEPS (Diluted)
-35.7% YoYTotal Assets
-12.0% YoYTotal Debt
-16.8% YoYOp. Cash Flow
-72.7% YoYFree Cash Flow
+126.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $151.8M -15.8% | $180.3M -7.9% | $195.9M +16.1% | $168.8M +26.6% | $133.3M +112.4% | $62.8M |
| Net Income | $-11.7M -45.5% | $-8.0M -89.1% | $-4.2M +71.1% | $-14.7M -239.1% | $10.6M +39.3% | $7.6M |
| Operating Income | $-11.6M -630.3% | $-1.6M -116.3% | $9.7M +313.9% | $-4.5M -128.8% | $15.8M +57.2% | $10.0M |
| EPS (Diluted) | $-0.19 -35.7% | $-0.14 -75.0% | $-0.08 +69.2% | $-0.26 -2500.0% | $-0.01 | — |
| Total Assets | $187.3M -12.0% | $212.8M +4.3% | $204.0M +1.6% | $200.8M +0.1% | $200.6M +11.7% | $179.6M |
| Total Debt | $61.5M -16.8% | $74.0M +0.3% | $73.8M -13.9% | $85.7M +2.7% | $83.5M +153.5% | $32.9M |
| Operating Cash Flow | $3.1M -72.7% | $11.3M -52.6% | $24.0M -2.0% | $24.4M -8.2% | $26.6M +90.8% | $14.0M |
| Free Cash Flow | $692.0K +126.0% | $-2.7M -118.9% | $14.0M +21.8% | $11.5M -40.9% | $19.5M +90.1% | $10.3M |
Get alerted when AIRS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Airsculpt Technologies, Inc. including:
Top Institutional Holders of AIRS
Vesey Street Capital Partners, L.L.C.
$136.5M30,324,180 shTHRIVENT FINANCIAL FOR LUTHERANS
$19.9M4,425,000 shBlackRock, Inc.
$5.8M1,278,871 shWEXFORD CAPITAL LP
$3.8M841,734 shUBS Group AG
$3.6M792,183 shFourWorld Capital Management LLC
$3.4M750,000 shFLPUTNAM INVESTMENT MANAGEMENT CO
$3.1M691,989 shAQR CAPITAL MANAGEMENT LLC
$2.1M470,723 shGEODE CAPITAL MANAGEMENT, LLC
$2.0M451,224 shGSA CAPITAL PARTNERS LLP
$1.9M425,186 sh
| Fund | Value | Shares |
|---|---|---|
| Vesey Street Capital Partners, L.L.C. | $136.5M | 30,324,180 |
| THRIVENT FINANCIAL FOR LUTHERANS | $19.9M | 4,425,000 |
| BlackRock, Inc. | $5.8M | 1,278,871 |
| WEXFORD CAPITAL LP | $3.8M | 841,734 |
| UBS Group AG | $3.6M | 792,183 |
| FourWorld Capital Management LLC | $3.4M | 750,000 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $3.1M | 691,989 |
| AQR CAPITAL MANAGEMENT LLC | $2.1M | 470,723 |
| GEODE CAPITAL MANAGEMENT, LLC | $2.0M | 451,224 |
| GSA CAPITAL PARTNERS LLP | $1.9M | 425,186 |
Companies Similar to AIRS
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
CUMBERLAND PHARMACEUTICALS INC
Starling Oncology, Inc.
EXAGEN INC.
Organogenesis Holdings Inc.
Maze Therapeutics, Inc.
Pelthos Therapeutics Inc.
Neuronetics, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put AIRS on your watchlist
Track score changes the day Airsculpt Technologies, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is AIRS a good stock to buy?
13F Pro's AI-powered analysis of Airsculpt Technologies, Inc. (AIRS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AIRS are available on the AIRS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. AIRS is classified as a small company.
Which hedge funds own AIRS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AIRS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Airsculpt Technologies, Inc.'s investment landscape.